8-K - Gain Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On November 28, 2025, Gain Therapeutics, Inc. (the “Company”), filed a prospectus supplement (the “Prospectus Supplement”) with the U.S. Securit

Other Event

$35.5M$14.5M$35.5M

9.01

. Financial Statements and Exhibits. (d) Exhibits The exhibits listed below are furnished as part of this Current Report on Form 8-K. Exhibit No. Description 5.

Exhibits Only

Exhibits (2)

5.1

EXHIBIT 5.1

8-K

FORM 8-K